May 21st, 2025 | 07:00 CEST
Stocks on the verge of MULTIPLYING? BioNTech, D-Wave, and hot stock Argo Living Soils aim to revolutionize their markets! Buy now?
These companies want to turn billion-dollar markets upside down: Argo Living Soils, BioNTech, and D-Wave. Argo Living Soils aims to revolutionize infrastructure construction through nanotechnology. Concrete and asphalt are to become more durable and environmentally friendly through nanotechnology. This could, for example, make buildings and bridges better protected against earthquakes. The potential is enormous, and the hot stock is valued at less than CAD 10 million, offering the chance for a multiple increase. D-Wave has impressively demonstrated how quickly a revaluation can take place. Quantum computing has the potential to change the world. But big players like Alphabet, NVIDIA, and others also want a big piece of the pie. At BioNTech, the focus remains on the fight against cancer. The stock appears to have halted its sell-off, but analysts are lowering their price targets. Where is the right entry point now?
time to read: 4 minutes
|
Author:
Fabian Lorenz
ISIN:
BIONTECH SE SPON. ADRS 1 | US09075V1026 , D-WAVE QUANTUM INC | US26740W1099 , ARGO LIVING SOILS CORP | CA04018T3064
Table of contents:
Author
Fabian Lorenz
For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
Tag cloud
Shares cloud
Agro Living Soils aims to revolutionize the construction industry with nanotechnology
Argo Living Soils aims to revolutionize infrastructure construction with nanotechnology. To this end, the Canadians are working on the next generation of concrete and asphalt. In the future, these materials will not only be more resource-efficient in production, but also more stable and durable. A few weeks ago, a cooperation with Graphene Leaders Canada was announced. Together, the partners want to work on adding graphene nanoplatelets (GNP) to concrete and asphalt.
Like the more familiar graphite, the nanomaterial graphene is made from carbon. Due to its lightness and near transparency, it is often referred to as a "miracle material." Although only one atom thick, is over 100 times stronger than steel and electrically conductive. Graphene can also be combined with other materials such as plastic. This "miracle material" is already being used in computer chips, medical technology, and energy storage devices.
Argo Living Soils now wants to bring graphene nanoplatelets (GNP) to the construction industry for stronger, more environmentally friendly infrastructure solutions. Incorporating graphene into concrete is expected to offer revolutionary advantages: It is expected to increase concrete's compressive and tensile strength by up to 30%, enabling structures with greater durability but less material. This could make buildings and bridges significantly more earthquake-resistant, for example. At the same time, the carbon footprint of concrete production, which causes high emissions, could be improved considerably. Using less cement should reduce CO2 emissions by up to 20%. In addition, the amount of water required for mixing concrete should be reduced. Similar advantages should be achieved when added to asphalt.
If the development proves successful, the revenue potential would be enormous: While the global asphalt market has a volume of USD 82 billion, the concrete market is worth as much as USD 250 billion - with both markets continuing to grow. Given this potential, the current valuation of under CAD 10 million seems worth speculating on. The next press releases are likely to be exciting.
D-Wave Quantum: Outshining supercomputers
Agro Living Soils is heading in the same direction as D-Wave: industrial applications. In recent months, quantum computing has impressively demonstrated how quickly a topic of the future can become reality. Since November, D-Wave's share price has increased more than tenfold and is now worth almost USD 4 billion on the stock market. After sharp corrections in January and April, the USD 13 mark was broken in recent days and new all-time highs were reached. With expected annual revenue of just over USD 24 million, the valuation is certainly ambitious - but so is the potential. Many experts compare it to NVIDIA and the artificial intelligence of 10 years ago. However, a breakthrough in quantum computing could come even faster.
Quantum computers promise to solve complex problems in areas such as optimization, cryptography, and simulations at speeds that will dwarf everything we know today. D-Wave is considered one of the pioneers of real-world applications. The Advantage2 system, based on quantum annealing technology, has now solved a simulation in just a few minutes that would have taken a classic supercomputer nearly 1 million years.
In the first quarter of 2025, D-Wave Quantum's revenue exploded by 509% to USD 15 million. This means that analysts' estimates for the current year could also prove to be too low. On the other hand, more and more tech giants such as Alphabet, Microsoft, and NVIDIA are entering the market. So the race is only just beginning.
BioNTech: Fighting cancer
BioNTech aims to revolutionize the fight against cancer. The German biotech flagship has a full development pipeline and high cash reserves.
When announcing the first quarter figures, CEO Prof. Dr. Ugur Sahin said: "In the first quarter of 2025, we continued to implement our strategic priorities consistently. This is demonstrated by data updates on our bispecific PD-L1xVEGF-A antibody candidate BNT327 and clinical progress in our focus programs and combination therapy approaches."
The Company is advancing the development of its oncology pipeline. The strategic focus is on two pan-tumor programs: the immunomodulator candidate BNT327, a bispecific antibody targeting PD-L1 and VEGF-A, and mRNA cancer immunotherapy candidates. Promising clinical updates included initial data for the innovative combination of BNT327 with an antibody-drug conjugate (ADC) candidate.
BioNTech shares appear to have halted their slide this year from over EUR 120 to EUR 80. H.C. Wainwright recently confirmed its "Buy" recommendation for the German biotech company's shares. However, the price target was reduced from USD 145 to USD 134.
Agro Living Soils is a hot stock with huge potential. Given its potential and current market capitalization, investors can get in early. The D-Wave share has shown how quickly a tenfold increase is possible. It currently has a lot of momentum. However, the big tech giants will not let the first mover have the cake without a fight. BioNTech is expected to release further important data this year. If this is positive, the stock is currently anything but expensive.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.
In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
For this reason, there is a concrete conflict of interest.
The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.
Risk notice
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.
The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.
